Rayonier Advanced Materials: Tariff Fears Overdone, Initiate With Strong Buy
We rate RYAM a strong buy with a $10 price target, citing a rare risk/reward skew as distress-level valuation ignores a specialty cellulose recovery. Specialty cellulose margins are expanding due to mix shifts, pricing power, and operational discipline, with EBITDA set to rise despite near-term volume headwinds. The market underappreciates RYAM's biomaterials and bioethanol ramp, which offers structural earnings growth and regulatory tailwinds, yet receives minimal valuation credit.
Rayonier (RYN) Up 0.8% Since Last Earnings Report: Can It Continue?
Rayonier (RYN) reported earnings 30 days ago. What's next for the stock?
Rayonier: A Buy On Potential Tariff Tailwinds And Capital Management Upside
I maintain my Buy rating on Rayonier; the company is a potential winner in the ongoing trade war and it could adopt value-enhancing capital allocation initiatives. Given its geographical concentration in the U.S., RYN stands to benefit from tariffs on specific lumber imports. The pending sale of its New Zealand JV stake will unlock significant cash, enabling debt reduction and shareholder returns.
Rayonier Inc. (RYN) Q1 2025 Earnings Conference Call Transcript
Rayonier Inc. (NYSE:RYN ) Q1 2025 Earnings Conference Call May 1, 2025 10:00 AM ET Company Participants Collin Mings - VP, Capital Markets and Strategic Planning Mark McHugh - President and CEO April Tice - SVP and CFO Doug Long - EVP and CRO Conference Call Participants Matthew McKellar - RBC Capital Markets Anthony Pettinari - Citigroup Ketan Mamtora - BMO Capital Markets Operator Welcome and thank you for joining Rayonier's First Quarter 2025 Conference Call. At this time, all participants are in a listen-only mode.
Rayonier's Q1 Earnings Miss Estimates, Revenues Decline Y/Y
RYN's Q1 earnings reflect a decline in pro-forma operating income from its Southern Timber and Real Estate segments.
Rayonier (RYN) Reports Q1 Loss, Lags Revenue Estimates
Rayonier (RYN) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.08. This compares to earnings of $0.05 per share a year ago.
Best Income Stocks to Buy for April 29th
WTBA, RYN and THFF made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 29, 2025.
Rayonier Stock Rises 9.6% in a Month: Will the Trend Continue?
RYN is likely to gain from its geographical diversity, long-term value of HBU development, and recent developments in the field of biogenetics and cloning.
Rayonier to Sell its Stake in New Zealand JV to TRG for $710M
To focus on core U.S. markets, RYN is set to sell its entire 77% stake in its New Zealand joint venture to The Rohatyn Group's Ents LP fund.
Rayonier (RYN) Up 2.1% Since Last Earnings Report: Can It Continue?
Rayonier (RYN) reported earnings 30 days ago. What's next for the stock?
Rayonier Advanced Q4 Earnings Beat Estimates, Margins Improve Y/Y
RYAM reports improved margins in Q4 despite flat sales compared with the year-ago quarter.
Rayonier Vs. Barrick: Paper Covers Pet Rock
Inflation hedges are an important part of an overall portfolio construction. Unfortunately most investors chase assets without understanding the value they offer. We go over two popular inflation hedges and tell you why we bought one.
